XML 61 R40.htm IDEA: XBRL DOCUMENT
v3.24.1.1.u2

Intangible Assets (Tables) | 12 Months Ended
--- | ---
Mar. 31, 2024
Intangible Assets, Net (Excluding Goodwill) [Abstract] |
Reconciliation of the Activity Affecting Intangible Assets | A reconciliation of the activity affecting intangible assets, net for each of 2024 and 2023 is as follows:
| Year Ended March 31, 2024
(In thousands) | Indefinite- Lived Tradenames |  | Finite-Lived Tradenames and Customer Relationships |  | Totals
Gross Carrying Amounts |  |  |  |  |
Balance – March 31, 2023 | $ | 2,168,902 |  |  | $ | 411,118 |  |  | $ | 2,580,020 |
Additions (a) | 393 |  |  | 680 |  |  | 1,073 |
Effects of foreign currency exchange rates | (2,133) |  |  | (540) |  |  | (2,673) |
Balance – March 31, 2024 | $ | 2,167,162 |  |  | $ | 411,258 |  |  | $ | 2,578,420 |
Accumulated Amortization |  |  |  |  |
Balance – March 31, 2023 | $ | — |  |  | $ | 238,127 |  |  | $ | 238,127 |
Additions | — |  |  | 19,784 |  |  | 19,784 |
Effects of foreign currency exchange rates | — |  |  | (74) |  |  | (74) |
Balance – March 31, 2024 | $ | — |  |  | $ | 257,837 |  |  | $ | 257,837 |
Intangible assets, net – March 31, 2024 | $ | 2,167,162 |  |  | $ | 153,421 |  |  | $ | 2,320,583 |
Intangible Assets, net by Reportable Segment: |  |  |  |  |
North American OTC Healthcare | $ | 2,092,853 |  |  | $ | 135,932 |  |  | $ | 2,228,785 |
International OTC Healthcare | 74,309 |  |  | 17,489 |  |  | 91,798 |
Intangible assets, net – March 31, 2024 | $ | 2,167,162 |  |  | $ | 153,421 |  |  | $ | 2,320,583 |
(a) On January 8, 2024, our Australian subsidiary acquired one of its suppliers. In connection with this acquisition, we preliminarily allocated $1.1 million to intangible assets.
| Year Ended March 31, 2023
(In thousands) | Indefinite- Lived Tradenames |  | Finite-Lived Tradenames and Customer Relationships |  |  | Totals
Gross Carrying Amounts |  |  |  |  |  |
Balance – March 31, 2022 | $ | 2,476,559 |  |  | $ | 436,174 |  |  |  | $ | 2,912,733 |
Tradename impairment | (298,664) |  |  | (22,748) |  |  |  | (321,412) |
Effects of foreign currency exchange rates | (8,993) |  |  | (2,308) |  |  |  | (11,301) |
Balance – March 31, 2023 | $ | 2,168,902 |  |  | $ | 411,118 |  |  |  | $ | 2,580,020 |
Accumulated Amortization |  |  |  |  |  |
Balance – March 31, 2022 | $ | — |  |  | $ | 216,098 |  |  |  | $ | 216,098 |
Additions | — |  |  | 22,266 |  |  |  | 22,266 |
Effects of foreign currency exchange rates | — |  |  | (237) |  |  |  | (237) |
Balance – March 31, 2023 | $ | — |  |  | $ | 238,127 |  |  |  | $ | 238,127 |
Intangible assets, net – March 31, 2023 | $ | 2,168,902 |  |  | $ | 172,991 |  |  |  | $ | 2,341,893 |
Intangible Assets, net by Reportable Segment: |  |  |  |  |  |
North American OTC Healthcare | $ | 2,092,852 |  |  | $ | 154,552 |  |  |  | $ | 2,247,404 |
International OTC Healthcare | 76,050 |  |  | 18,439 |  |  |  | 94,489 |
Intangible assets, net – March 31, 2023 | $ | 2,168,902 |  |  | $ | 172,991 |  |  |  | $ | 2,341,893 |
Schedule of Expected Amortization Expense | At March 31, 2024, finite-lived intangible assets are expected to be amortized over their estimated useful lives, which ranges from a period of 10 to 24 years, and the estimated amortization expense for each of the five succeeding years and periods thereafter is as follows (in thousands):
(In thousands) |
Year Ending March 31, | Amount
2025 | $ | 18,139 |
2026 | 16,189 |
2027 | 14,597 |
2028 | 12,262 |
2029 | 12,262 |
Thereafter | 79,972 |
| $ | 153,421 |

X
- Definition Schedule of Intangible Assets [Table Text Block] + References No definition available. + Details
Name: | pbh_ScheduleOfIntangibleAssetsTableTextBlock
Namespace Prefix: | pbh_
Data Type: | dtr-types1:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2 + Details
Name: | us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration